Allianz Asset Management GmbH Acquires 13,553 Shares of STERIS plc $STE

Allianz Asset Management GmbH increased its holdings in shares of STERIS plc (NYSE:STE) by 16.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 93,905 shares of the medical equipment provider’s stock after purchasing an additional 13,553 shares during the quarter. Allianz Asset Management GmbH owned 0.10% of STERIS worth $23,236,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Mediolanum International Funds Ltd boosted its holdings in shares of STERIS by 9.0% in the second quarter. Mediolanum International Funds Ltd now owns 62,327 shares of the medical equipment provider’s stock worth $14,883,000 after buying an additional 5,156 shares during the last quarter. Entropy Technologies LP increased its holdings in STERIS by 282.2% during the second quarter. Entropy Technologies LP now owns 9,099 shares of the medical equipment provider’s stock valued at $2,186,000 after buying an additional 6,718 shares during the last quarter. Vanguard Group Inc. raised its holdings in STERIS by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 12,163,128 shares of the medical equipment provider’s stock worth $2,921,827,000 after purchasing an additional 205,276 shares during the period. Asset Management One Co. Ltd. raised its stake in shares of STERIS by 5.4% in the third quarter. Asset Management One Co. Ltd. now owns 98,487 shares of the medical equipment provider’s stock worth $24,366,000 after buying an additional 5,072 shares during the period. Finally, Cerity Partners LLC raised its stake in STERIS by 28.8% during the 3rd quarter. Cerity Partners LLC now owns 96,853 shares of the medical equipment provider’s stock worth $23,966,000 after acquiring an additional 21,656 shares during the period. Institutional investors own 94.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $275.20.

Insider Buying and Selling at STERIS

In other news, VP John Adam Zangerle sold 15,000 shares of the business’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total value of $3,977,100.00. Following the sale, the vice president directly owned 33,669 shares in the company, valued at $8,926,998.66. The trade was a 30.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Renato Tamaro sold 5,036 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total value of $1,297,021.80. Following the sale, the vice president directly owned 5,695 shares in the company, valued at $1,466,747.25. The trade was a 46.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 25,044 shares of company stock worth $6,586,218 over the last 90 days. 1.07% of the stock is owned by insiders.

STERIS Trading Up 3.5%

Shares of STERIS stock opened at $252.25 on Friday. STERIS plc has a twelve month low of $204.90 and a twelve month high of $269.44. The company has a quick ratio of 1.63, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. The business has a 50-day moving average price of $258.42 and a 200-day moving average price of $249.71. The firm has a market cap of $24.76 billion, a price-to-earnings ratio of 35.18 and a beta of 1.03.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.The business had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter last year, the business posted $2.32 EPS. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities research analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Tuesday, February 17th will be paid a dividend of $0.63 per share. The ex-dividend date of this dividend is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s dividend payout ratio is presently 36.21%.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.